Categories
allPost

Sam Altman goes to Microsoft after ouster, OpenAI employees threaten to quit

8 people 👁️ing this randomly

Sam Altman goes to Microsoft after ouster, OpenAI employees threaten to quit

Sam Altman was ousted as CEO of OpenAI — the company behind artificial intelligence tool ChatGPT — and scooped up by Microsoft. Now employees at the company he co-founded are threatening to quit over his exit. NBC News’ Christine Romans has details. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows. Connect with NBC News Online! NBC News App: https://smart.link/5d0cd9df61b80 Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Get more of NBC News delivered to your inbox: nbcnews.com/newsletters #SamAltman #Microsoft #OpenAI

*NBC News*

Sam Altman goes to Microsoft after ouster, OpenAI employees threaten to quit


Full/More Story on Source:

Dillard's - The Style of Your Life.

By allaboutian

open profile for all

Related Posts

The family behind this year’s Rockefeller Center Christmas Tree

0 people 👁️ing this randomly The family behind this year’s Rockefeller Center Christmas Tree Before…

A.I. chatbot responses linked to surge in eating disorders

2 people 👁️ing this randomly A.I. chatbot responses linked to surge in eating disorders A…

Dog pharma company clears FDA hurdle for lifespan extending drug

2 people 👁️ing this randomly Dog pharma company clears FDA hurdle for lifespan extending drug…